Zinc/ Bismuth Subgallate/ Bismuth Oxide
Indications
Registered South African indications:
- Haemorrhoids
Cautions
Contraindications
- Hypersensitivity to the active ingredients or any of the excipients in this combination product
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Rectal bleeding
- Blood in the stool
Adult dosage
Forms avail. in SA and covered in this monograph: sup
Haemorrhoids
Other related anorectal conditions
Zinc/ Bismuth Subgallate/ Bismuth oxide
296/59/24 (mg)
- Rectal (sup): 1 sup, in the morning, at bedtime and after every evacuation
Insert as deeply into the anus as possible
Paediatric dosage
Not recommended for use in children
Special populations
Pregnancy
- Caution
- Whilst formal studies on the effect of this product during human pregnancy have not been conducted, there is no epidemiological evidence of adverse effect, either to the pregnant mother or foetus
- This product should not be used during pregnancy unless the potential benefit of treatment to the mother outweighs the possible risk to the developing foetus
Breastfeeding
- Caution; not recommended
- This product should not be used during breastfeeding unless the potential benefit of treatment to the mother outweighs the possible risk to the breastfeeding infant
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Skin and Subcutaneous Tissue Disorders
- Application site reactions
- Burn
- Erythema
- Exfoliation
- Irritation
- Pain
- Pruritus
- Rash
- Urticaria
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity
Interactions
None known
Monitoring
None routine
Prescribing points
Persistence or worsening of symptoms
- If symptoms persist or worsen, patients should be instructed to stop use and consult a doctor
Mechanism of action
Zinc, bismuth subgallate and bismuth oxide provide antiseptic, astringent and emollient properties which help to relieve discomfort associated with minor ano-rectal conditions. This results in a protective action on mucous membranes and raw surfaces.
Dosage forms
- Suppository
Formulation
Zinc/Bismuth Subgallate/Bismuth oxide is available in several formulations. Please note the list below gives examples of products which are available and is not necessarily comprehensive. The listing of a product does not constitute endorsement of the product by EMGuidance; likewise, failure to list a product does not imply that EMGuidance disapproves of the product. This information is put together on the basis of the National Government's Medicines Price Registry at the time of publication.
COMBINATION PREPARATIONS
Zinc/ Bismuth subgallate/ Bismuth oxide
Suppository 296mg/59mg/24mg
- Anusol (Johnson & Johnson) originator
References
1. PI: Anusol suppositories, Johnson & Johnson (Pty)Ltd:Date of registration: 2 April 1997 [https://drive.google.com/drive/folders/1cBGXz0XMAMZe3Og-8cRXqU9PKrjsCTwp] 2. SmPC: Anusol Suppositories, Church & Dwight UK Ltd:Last updated on eMC: 13 Apr 2018; Downloaded online 3 Apr 2019 [https://www.medicines.org.uk/emc/medicine/7164] 3. MIMS; 08 Jun 2017 [https://drive.google.com/drive/folders/1cBGXz0XMAMZe3Og-8cRXqU9PKrjsCTwp] 4. NAPOS: The Drug Database for Acute Porphyria: Anusol; Accessed online 03 Apr 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=C05AX02&l=gbr] 5. South African Institute for Drug-Free Sport: Anusol; Accessed online 03 Apr 2019 [http://www.drugfreesport.org.za/online-medication-check/]
Brands & products
0 products · cached snapshot- Anusol
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.